Literature DB >> 22425471

Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia.

Derek J Fisher1, Bryan Grant, Dylan M Smith, Giuseppe Borracci, Alain Labelle, Verner J Knott.   

Abstract

Elevated smoking rates have been noted in schizophrenia, and it has been hypothetically attributed to nicotine's ameliorating abnormal brain processes in this illness. There is some preliminary evidence that nicotine may alter pre-attentive auditory change detection, as indexed by the EEG-derived mismatch negativity (MMN), but no previous study has examined what role auditory verbal hallucinations (AVH) may have on these effects. The objective of this study was to examine MMN-indexed acoustic change detection in schizophrenia (SZ) following nicotine administration and elucidate its association with AVH. Using a modified multi-feature paradigm, MMNs to duration, frequency and intensity deviants were recorded in 12 schizophrenia outpatients (SZ) with persistent AVHs following nicotine (6mg) and placebo administration. Electrical activity was recorded from 32 scalp electrodes; MMN amplitudes and latencies for each deviant were compared between treatments and were correlated with trait (PSYRATS) and state measures of AVH severity and Positive and Negative Syndrome Scale (PANSS) ratings. Nicotine administration resulted in a shortened latency for intensity MMN. Additionally, nicotine-related change in MMN amplitude was correlated with nicotine-related change in subjective measures of hallucinatory state. In summary, nicotine did not affect MMN amplitudes in schizophrenia patients with persistent AVHs, however this study reports accelerated auditory change detection to intensity deviants with nicotine in this group. Additionally, nicotine appeared to induce a generalized activation of the auditory cortex in schizophrenia, resulting in a concurrent increase in intensity MMN amplitude and subjective clarity of AVHs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425471     DOI: 10.1016/j.psychres.2012.01.026

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  14 in total

1.  Online comments on smoking bans in psychiatric hospitals units.

Authors:  Cati G Brown-Johnson; Ashley Sanders-Jackson; Judith J Prochaska
Journal:  J Dual Diagn       Date:  2014

2.  Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.

Authors:  Holly K Hamilton; Deepak C D'Souza; Judith M Ford; Brian J Roach; Naomi S Kort; Kyung-Heup Ahn; Savita Bhakta; Mohini Ranganathan; Daniel H Mathalon
Journal:  Schizophr Res       Date:  2017-07-12       Impact factor: 4.939

Review 3.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

4.  Auditory mismatch impairments are characterized by core neural dysfunctions in schizophrenia.

Authors:  Arnim Johannes Gaebler; Klaus Mathiak; Jan Willem Koten; Andrea Anna König; Yury Koush; David Weyer; Conny Depner; Simeon Matentzoglu; James Christopher Edgar; Klaus Willmes; Mikhail Zvyagintsev
Journal:  Brain       Date:  2015-03-04       Impact factor: 13.501

5.  Hallucinations, neuroplasticity, and prediction errors in schizophrenia.

Authors:  Amanda McCleery; Jonathan K Wynn; Daniel H Mathalon; Michael F Green
Journal:  Scand J Psychol       Date:  2018-02

6.  Effects of acute nicotine on auditory change-related cortical responses.

Authors:  Naofumi Otsuru; Aki Tsuruhara; Eishi Motomura; Hisashi Tanii; Makoto Nishihara; Koji Inui; Ryusuke Kakigi
Journal:  Psychopharmacology (Berl)       Date:  2012-06-17       Impact factor: 4.530

7.  Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: altered MMN to violations of an auditory gestalt.

Authors:  Erica D Rudolph; Emma M L Ells; Debra J Campbell; Shelagh C Abriel; Philip G Tibbo; Dean F Salisbury; Derek J Fisher
Journal:  Schizophr Res       Date:  2015-06-10       Impact factor: 4.939

8.  Smoking among individuals with schizophrenia in Korea: gender differences.

Authors:  Sun S Kim; Sangkeun Chung; Jong-Il Park; Ae-Ja Jung; David Kalman; Douglas M Ziedonis
Journal:  Arch Psychiatr Nurs       Date:  2013-07-26       Impact factor: 2.218

9.  CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study.

Authors:  Joelle Choueiry; Crystal M Blais; Dhrasti Shah; Dylan Smith; Derek Fisher; Vadim Illivitsky; Verner Knott
Journal:  Psychopharmacology (Berl)       Date:  2020-08-27       Impact factor: 4.530

Review 10.  Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

Authors:  Douglas L Boggs; Jon Carlson; Jose Cortes-Briones; John H Krystal; D Cyril D'Souza
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.